| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |